Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdiaVita and Glutathione in Autism Spectrum Disorder
NCT07622316Phase 1Recruiting
- Sponsor
- Greater Atlanta Integrative Pediatrics
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of AdiaVita in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Greater Atlanta Integrative Pediatrics. Primary endpoint: Autism Treatment Evaluation Checklist at 6 months. Started Jun 2026; status: recruiting.
02
Drugs
AdiaVita
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07622316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07622316.